UNITED THERAPEUTICS CORPORATION
UTHR US91307C1027
United States 19801
US-DE Wilmington c/o THE CORPORATION TRUST COMPANY, CORPORATION TRUST CENTER 1209 ORANGE ST
Registration Number 2638178
United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Most of the company's sales are generated within the United States. United Therapeutics also markets a pediatric oncology drug, but its focus largely remains in pulmonary arterial hypertension.
Annual Performance 1
| 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| 73% | 40% | 32% | -20% | 58% |
Historical Performance 1
| 1M | 3M | 6M | 1Y | 3Y | 5Y | All Time |
|---|---|---|---|---|---|---|
| 0% | 9% | 48% | 57% | 212% | 175% | 131% |
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Transactions: 135 Insiders: 8
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| MAHON PAUL A |
360.16 USD |
7,700 Sold |
2,773,232 USD |
19/12/2024 | 19/12/2024 |
| SULLIVAN LOUIS W |
381.41 USD |
620 Sold |
236,475 USD |
18/12/2024 | 18/12/2024 |
| SULLIVAN LOUIS W |
366.11 USD |
1,121 Sold |
410,407 USD |
18/12/2024 | 18/12/2024 |
| SULLIVAN LOUIS W |
369.32 USD |
2,100 Sold |
775,563 USD |
18/12/2024 | 18/12/2024 |
| SULLIVAN LOUIS W |
366.97 USD |
600 Sold |
220,184 USD |
18/12/2024 | 18/12/2024 |
| SULLIVAN LOUIS W |
368.50 USD |
1,307 Sold |
481,632 USD |
18/12/2024 | 18/12/2024 |
| SULLIVAN LOUIS W |
380.12 USD |
700 Sold |
266,084 USD |
18/12/2024 | 18/12/2024 |
| SULLIVAN LOUIS W |
370.78 USD |
100 Sold |
37,078 USD |
18/12/2024 | 18/12/2024 |
| SULLIVAN LOUIS W |
374.46 USD |
500 Sold |
187,228 USD |
18/12/2024 | 18/12/2024 |
| SULLIVAN LOUIS W |
375.00 USD |
2,200 Sold |
825,007 USD |
18/12/2024 | 18/12/2024 |